FDA Permits New Sunscreen Ingredient After 20 Years

1

The FDA has added bemotrizinol to the OTC sunscreen monograph, marking the first new active ingredient since the late 1990s.
2

Bemotrizinol offers protection against both UVA and UVB radiation and has low systemic absorption when used topically.
3

The FDA considers bemotrizinol generally recognized as safe and effective for adults and children aged 6 months and older.
4

The ingredient can be used in OTC sunscreen products that comply with monograph requirements, but does not approve specific products.
5

Bemotrizinol was previously marketed in Europe and other countries before its authorization in the U.S. under a streamlined process.